Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2014 1
2019 2
2020 4
2021 5
2022 12
2023 8
2024 5
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
An Update on Appendiceal Neuroendocrine Tumors.
Andrini E, Lamberti G, Alberici L, Ricci C, Campana D. Andrini E, et al. Curr Treat Options Oncol. 2023 Jul;24(7):742-756. doi: 10.1007/s11864-023-01093-0. Epub 2023 May 4. Curr Treat Options Oncol. 2023. PMID: 37140773 Free PMC article. Review.
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study.
Lamberti G, Rihawi K, Mazzoni F, Riccardi F, Follador A, Tiseo M, Frassoldati A, Colantonio I, Bonetti A, Genova C, Giardina D, Bertolini F, Cinieri S, Pasello G, Brighenti M, Andrini E, Tognetto M, Boni L, Ardizzoni A; GOIRC group. Lamberti G, et al. Among authors: andrini e. J Immunother Cancer. 2025 May 7;13(5):e010694. doi: 10.1136/jitc-2024-010694. J Immunother Cancer. 2025. PMID: 40341031 Free PMC article. Clinical Trial.
Classic versus innovative strategies for immuno-therapy in pancreatic cancer.
Formelli MG, Palloni A, Tavolari S, Deiana C, Andrini E, Di Marco M, Campana D, Lamberti G, Brandi G. Formelli MG, et al. Among authors: andrini e. Adv Drug Deliv Rev. 2025 Oct;225:115671. doi: 10.1016/j.addr.2025.115671. Epub 2025 Aug 7. Adv Drug Deliv Rev. 2025. PMID: 40783052 Free article. Review.
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer.
Ricciuti B, Mira A, Andrini E, Scaparone P, Michelina SV, Pecci F, Cantini L, De Giglio A, Lamberti G, Ambrogio C, Metro G. Ricciuti B, et al. Among authors: andrini e. Drugs Context. 2022 Nov 16;11:2022-7-4. doi: 10.7573/dic.2022-7-4. eCollection 2022. Drugs Context. 2022. PMID: 36452878 Free PMC article. Review.
Non-small-cell lung cancer: how to manage RET-positive disease.
Andrini E, Mosca M, Galvani L, Sperandi F, Ricciuti B, Metro G, Lamberti G. Andrini E, et al. Drugs Context. 2022 Jul 11;11:2022-1-5. doi: 10.7573/dic.2022-1-5. eCollection 2022. Drugs Context. 2022. PMID: 35912003 Free PMC article. Review.
44 results